arrow
返回
K

Kim Margolin

City of Hope

82H指数
493论文数
3.5W被引数
收录论文 105
发表时间
Results from monotherapy dose escalation of MDNA11, a long-acting IL-2 superkine, in a phase 1/2 trial show evidence of single-agent activity in advanced solid tumors
err2024-04-05
err1
PREAI
errAtkinson, Victoria G.; Antras, Jesus F.; Bedard, Philippe; Brenner, Warren; Brown, Jacqueline; Lemech, Charlotte R.; Lloyd, Peter; Margolin, Kim; Mathew, Matthen; Park, John J.; Thomas, Sajeve; Twardowski, Przemyslaw; Gardner, Humphrey; Prawira, Amy; Coello, Melissa; Ebrahimimizadeh, Walead; To, Minh D.; Merchant, Rosemina; Karanam, Sudhir Madduri; Yavari, Arash; Siu, Lillian L.; Tawbi, Hussein A.; Ascierto, Paolo A.
err分享
err收藏
Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma
err2024-03-22
err0
PREAI
errCampbell, Katie M.; Bustami, Zaid; Chen, Daniel G.; Medina, Egmidio; Gonzalez, Cynthia R.; Aldeen, Nataly Naser; Baselga-Carretero, Ignacio; Vega-Crespo, Agustin; Maxey, Jessica; Chen, Jia M.; Kuklinski, Lawrence F.; Kendra, Kari L.; Chmielowski, Bartosz; Thach-Giao Truong; Khushalani, Nikhil I.; Collichio, Frances; Ikeguchi, Alexandra; Victor, Adrienne I.; Margolin, Kim; Sosman, Jeffrey A.; Patel, Sapna P.; Hu-Lieskovan, Siwen; Moon, James; Bellasea, Shay; Wells, Daniel K.; Spencer, Christine N.; Thompson, Marshall A.; Wu, Michael; Scumpia, Philip O.; VanderWalde, Ari; Ribas, Antoni
err分享
err收藏
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
err2023-11-14
err6
errOAAI
errIn, Gino K.; Ribeiro, Jennifer R.; Yin, Jun; Xiu, Joanne; Bustos, Matias A.; Ito, Fumito; Chow, Frances; Zada, Gabriel; Hwang, Lindsay; Salama, April K. S.; Park, Soo J.; Moser, Justin C.; Darabi, Sourat; Domingo-Musibay, Evidio; Ascierto, Maria L.; Margolin, Kim; Lutzky, Jose; Gibney, Geoffrey T.; Atkins, Michael B.; Izar, Benjamin; Hoon, Dave S. B.; Vanderwalde, Ari M.
err分享
err收藏
Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204
err2023-10-01
err0
errOAAI
errHuang, R.; Youssef, G.; Nelson, T.; Wen, P.; Forsyth, P.; Hodi, F. S.; Margolin, K. A.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Ernstoff, M. S.; Moschos, S. J.; Atkins, M. B.; Postow, M.; Reardon, D. A.; Grootendorst, D. J.; Askelson, M.; Ritchings, C.; Tawbi, H. A.
err分享
err收藏
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
err2023-08-17
err43
errOAAI
errVanderWalde, Ari; Bellasea, Shay L.; Kendra, Kari L.; Khushalani, Nikhil I.; Campbell, Katie M.; Scumpia, Philip O.; Kuklinski, Lawrence F.; Collichio, Frances; Sosman, Jeffrey A.; Ikeguchi, Alexandra; Victor, Adrienne I.; Truong, Thach-Giao; Chmielowski, Bartosz; Portnoy, David C.; Chen, Yuanbin; Margolin, Kim; Bane, Charles; Dasanu, Constantin A.; Johnson, Douglas B.; Eroglu, Zeynep; Chandra, Sunandana; Medina, Egmidio; Gonzalez, Cynthia R.; Baselga-Carretero, Ignacio; Vega-Crespo, Agustin; Garcilazo, Ivan Perez; Sharon, Elad; Hu-Lieskovan, Siwen; Patel, Sapna P.; Grossmann, Kenneth F.; Moon, James; Wu, Michael C.; Ribas, Antoni
err分享
err收藏
Results from an expanded phase 1 trial of botensilimab (BOT), a multifunctional anti-CTLA-4, plus balstilimab (BAL; anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)
err2023-06-01
err10
errOAAI
errBullock, A.; Fakih, M.; Gordon, M.; Tsimberidou, A.; El-Khoueiry, A.; Wilky, B.; Pimentel, A.; Margolin, K.; Mahadevan, D.; Balmanoukian, A.; Sanborn, R.; Schwartz, G.; Abou-Alfa, G.; Bockorny, B.; Moser, J.; Sharma, S.; Grossman, J.; Rosenthal, K.; O'Day, S.; Lenz, H.; Schlechter, B.
err分享
err收藏
Digital Spatial Profiler highlights a T and B cells inflamed tumor microenvironment in brain metastases derived from melanoma vs. non-melanoma solid tumors
err2023-04-04
err0
PREAI
errMendoza-Valderrey, Alberto; Kessler, Daria M.; Dettmann, Ethan; Li, Xinmin; Thompson, Sierra; Kolker, Steven E.; Margolin, Kim A.; Ascierto, Maria L.
err分享
err收藏
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma新辅助-辅助或仅辅助的Pembrolizumab治疗晚期黑色素瘤
err2023-03-02
err327
errOAAI
errPatel, Sapna P.; Othus, Megan; Chen, Yuanbin; Wright, G. Paul; Yost, Kathleen J.; Hyngstrom, John R.; Hu-Lieskovan, Siwen; Lao, Christopher D.; Fecher, Leslie A.; Truong, Thach-Giao; Eisenstein, Jennifer L.; Chandra, Sunandana; Sosman, Jeffrey A.; Kendra, Kari L.; Wu, Richard C.; Devoe, Craig E.; Deutsch, Gary B.; Hegde, Aparna; Khalil, Maya; Mangla, Ankit; Reese, Amy M.; Ross, Merrick I.; Poklepovic, Andrew S.; Phan, Giao Q.; Onitilo, Adedayo A.; Yasar, Demet G.; Powers, Benjamin C.; Doolittle, Gary C.; In, Gino K.; Kokot, Niels; Gibney, Geoffrey T.; Atkins, Michael B.; Shaheen, Montaser; Warneke, James A.; Ikeguchi, Alexandra; Najera, Jose E.; Chmielowski, Bartosz; Crompton, Joseph G.; Floyd, Justin D.; Hsueh, Eddy; Margolin, Kim A.; Chow, Warren A.; Grossmann, Kenneth F.; Dietrich, Eliana; Prieto, Victor G.; Lowe, Michael C.; Buchbinder, Elizabeth I.; Kirkwood, John M.; Korde, Larissa; Moon, James; Sharon, Elad; Sondak, Vernon K.; Ribas, Antoni
err分享
err收藏
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study肿瘤内溶瘤病毒V937联合ipilimumab治疗晚期黑色素瘤: MITCI 1b期研究
err2022-12-23
err13
errOAAI
errCurti, Brendan D.; Richards, Jon; Hyngstrom, John R.; Daniels, Gregory A.; Faries, Mark; Feun, Lynn; Margolin, Kim A.; Hallmeyer, Sigrun; Grose, Mark; Zhang, Yiwei; Li, Anlong; Andtbacka, Robert H., I
err分享
err收藏
How I treat brain metastases of melanoma
err2022-12-01
err8
errOAAI
errEroglu, Z.; Topcu, T. O.; Yu, H. M.; Margolin, K. A.
err分享
err收藏
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity下一代免疫肿瘤学策略:释放NK细胞活性
errCELLS
IF5.2
err2022-10-06
err5
errOAAI
errMendoza-Valderrey, Alberto; Alvarez, Maite; De Maria, Andrea; Margolin, Kim; Melero, Ignacio; Ascierto, Maria Libera
err分享
err收藏
Vidutolimod plus pembrolizumab as 2L+treatment in patients with antiePD-1erefractory melanoma and adrenal insufficiency: Subgroup analyses of a phase Ib study
err2022-09-01
err0
PREAI
errKirkwood, J. M.; Zakharia, Y.; Davar, D.; Buchbinder, E.; Medina, T.; Daud, A.; Ribas, A.; Chmielowski, B.; Niu, J. J.; Gibney, G. T.; Margolin, K. A.; Olszanski, A. J.; Mehmi, I.; Sato, T.; Shaheen, M.; Zhao, L.; Bobilev, D.; Krieg, A. M.; Wooldridge, J.; Milhem, M.
err分享
err收藏
Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer
err2022-06-01
err35
errOAAI
errBullock, A.; Grossman, J.; Fakih, M.; Lenz, H.; Gordon, M.; Margolin, K.; Wilky, B.; Mahadevan, D.; Trent, J.; Bockorny, B.; Moser, J.; Balmanoukian, A.; Schlechter, B.; Feliu, W. Ortuzar; Rosenthal, K.; Bullock, B.; Stebbing, J.; Godwin, J.; O'Day, S.; Tsimberidou, A.; El-Khoueiry, A.
err分享
err收藏
Tumor-infiltrating lymphocytes are associated with improved survival in node-positive Merkel cell carcinoma: A national cohort analysis
err2022-05-01
err2
PREAI
errCopeland, Amy R.; Shindorf, Mackenzie L.; McDonald, James D.; Hernandez, Jonathan M.; Davis, Jeremy L.; Margolin, Kim A.; Blakely, Andrew M.
err分享
err收藏
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer
err2022-02-08
err23
errOAAI
errEgelston, Colt A.; Guo, Weihua; Tan, Jiayi; Avalos, Christian; Simons, Diana L.; Lim, Min Hui; Huang, Yinghui J.; Nelson, Michael S.; Chowdhury, Arnab; Schmolze, Daniel B.; Yim, John H.; Kruper, Laura; Melstrom, Laleh; Margolin, Kim; Mortimer, Joanne E.; Yuan, Yuan; Waisman, James R.; Lee, Peter P.
err分享
err收藏
Mac Cheever (1944-2021): a tribute to a life of achievement and serviceMac Cheever (1944-2021): 向成就和服务的一生致敬
err2022-01-12
err0
errOAAI
errGreenberg, Philip D.; Disis, Mary L.; Margolin, Kim A.; Matrisian, Lynn M.; Sondel, Paul M.
err分享
err收藏
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States (vol 6, 100252, 2021)
err2021-12-01
err1
errOAAI
errJain, P.; Bugarin, J. Gutierrez; Guha, A.; Jain, C.; Patil, N.; Shen, T.; Stanevich, I.; Nikore, V.; Margolin, K.; Ernstoff, M.; Velcheti, V.; Barnholtz-Sloan, J.; Dowlati, A.
err分享
err收藏
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
err2021-10-01
err36
errOAAI
errJain, P.; Bugarin, J. Gutierrez; Guha, A.; Jain, C.; Patil, N.; Shen, T.; Stanevich, I.; Nikore, V.; Margolin, K.; Ernstoff, M.; Velcheti, V.; Barnholtz-Sloan, J.; Dowlati, A.
err分享
err收藏